Controlled Substances and DEA Requirements
Two registrations, one bottle
Controlled substances require the state TDDD and a federal DEA registration at the same address, for the schedules handled. Ohio scheduling follows the federal schedules; Ohio adds its reporting layer through OARRS.
Filling rules
- Schedule II - no refills; a new prescription each time. Emergency oral orders are limited to a seven-day supply with a written prescription following within seven days. Partial fills are permitted on patient request or pharmacy inability to supply, with the balance filled inside the federal window.
- Schedules III–V - up to five refills within six months of issue.
- Corresponding responsibility - the pharmacist must resolve red flags before dispensing: early refills, cash payment, long distance traveled, multiple prescribers, changed patterns. Document the resolution.
- OARRS - dispensers report controlled substance dispensing to the Ohio Automated Rx Reporting System by the next business day; pharmacists review it when red flags appear and document the review.
Records and security
Order Schedule II with DEA Form 222 or CSOS; maintain powers of attorney; keep a biennial inventory; store controlled substances in a securely locked, substantially constructed cabinet or dispersed per rule; report theft or significant loss to DEA and the Board promptly.
Worked example
A new patient presents 40 oxycodone 10 mg, paying cash, from a prescriber 90 miles away, 12 days after a 30-day fill at another pharmacy. The pharmacist checks OARRS, confirms overlapping fills, calls the prescriber, cannot verify, and declines to fill - documenting the red flags, the calls, and the refusal. That documented reasoning is what protects the license.
Traps
- Filling an aged Schedule II prescription without checking Ohio's fill window.
- Reporting to OARRS late instead of per the required schedule.
- Assuming a valid DEA number proves authority for that schedule or that patient.
- Skipping the power of attorney when a new buyer signs for Schedule II.